Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 813 results for "eli lilly"

Eli Lilly and (LLY) to Release Earnings on Thursday
American Banking News

Will Generics Eat Into Eli Lilly's (LLY) Q2 Earnings?

Eli Lilly and Company ( LLY ) is set to report second-quarter 2014 results on Jul 24. In the prior quarter, the company's earnings were in line with the Zacks Consensus Estimate. Moreover, the company posted an average positive earnings surprise of ... Yahoo! Finance, 1 hour ago
[x]  

398 images for eli lilly

American Banking News, 10 hours ago
Mideast Time, 3 days ago
Bidness Etc, 1 week ago
Bio Spectrum Asia, 2 days ago
I Stock Analyst, 1 week ago
Yahoo! Finance, 1 week ago
Indy Channel, 4 days ago
Jutia Group, 1 week ago
Fidelity Brokerage Services LLC, 2 weeks ago
Pharma Letter, 6 days ago
Bioresearch Online

ELI LILLY : Lilly and Immunocore Enter Immunotherapy Agreement to Co-Discover and Co-Develop Novel Cancer Therapies

By a News Reporter-Staff News Editor at Cancer Vaccine Week -- Eli Lilly and Company (NYSE: LLY) and Immunocore Limited announced they have entered into a co-discovery and co-development collaboration to research and potentially develop novel T ...
 4 Traders2 hours ago ELI LILLY : Recent Findings from Eli Lilly Has Provided New Information about Clinical Trials and Studies (Duloxetine Use in Employees with Low Back Pain:...  4 Traders2 hours ago Lilly and Immunocore Enter Immunotherapy Agreement to Co-Discover and Co-Develop Novel Cancer Therapies  HispanicBusiness.com1 hour ago Immunocore And Lilly Ink Immunotherapy Partnership  Bioresearch Online5 days ago
[x]  

Daiichi Sankyo and Eli Lilly and Company: Heart patients in England and Wales offered more choice of therapies as NICE extends recommendations for prasugrel

GERRARDS CROSS, England--(BUSINESS WIRE)--Jul. 23, 2014-- Revised guidance from the National Institute for Health and Care Excellence (NICE), recommends once-daily, oral antiplatelet prasugrel (Efient), in combination with aspirin, as a ...
 BusinessWeek10 hours ago UK's NICE changes guidance to recommend Eli Lilly's Efient for blood clots  Pharma Letter8 hours ago Daiichi Sankyo, Inc. And Eli Lilly and Company: Heart Patients In England And Wales Offered More Choice Of Therapies As National Institute for Clinical Excellence (NICE) Extends Recommendations For Prasugrel  BioSpace2 hours ago
[x]  

Eli Lilly (LLY) Breaks Through Resistance at $64.10

(SmarTrend(R) News Watch via COMTEX News Network) -- Eli Lilly (NYSE:LLY) has opened bullishly above the pivot of $63.77 today and has reached the first level of resistance at $64.10. Analysts will be watching for a cross of the next upside pivot ...
 PredictWallStreet3 hours ago Eli Lilly (LLY) Approaches New Upside Target of $64.30  Individual.com1 day ago
Scottrade

2014 Global Non-Hodgkin Lymphoma Therapeutics Market Report Featuring Bristol Myers Squibb, Celgen, Eli Lilly and Co, F. Hoffman La-Roche & GSK

Research and Markets (http://www.researchandmarkets.com/research/52q7th/global) has announced the addition of the "Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018" report to their offering. Non-Hodgkin lymphoma (NHL) is a condition of the ...
 Individual.com1 day ago The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune  Yahoo! Finance2 days ago Technical Pointers on Pharma Equities -- AbbVie, Johnson and Johnson, Merck, Bristol-Myers Squibb, and Eli Lilly  OSIX News2 days ago Research and Markets: 2014 Global Non-Hodgkin Lymphoma Therapeutics Market Report Featuring Bristol Myers Squibb, Celgen, Eli Lilly and Co, F. Hoffman La-Roche & GSK  TMC Net1 day ago
[x]  

Eli Lilly (LLY) Trading Near $62.42 Support Level

The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center Aare highlighting two trades on Eli Lilly and Co (http://www.marketintelligencecenter.com/symbol/LLY"LLY) today after it closed at ...
 Individual.com1 day ago Potential Eli Lilly (LLY) Trade Has 2.51% Downside Protection  Individual.com5 days ago
Bio Spectrum Asia

Eli Lilly to expand diabetes treatment portfolio in India

In its bid to enhance diabetes treatment portfolio in India, one of its important markets in Asia, US pharma major Eli Lilly and Company plans to launch a new product by the end of next year. The company that sells a range of medicines and drug ...
 Business Standard3 days ago Eli Lilly expanding diabetes portfolio in India  Bio Spectrum Asia2 days ago

A clear policy framework must: Edgard A Olaizola

Eli Lilly and Company, in the insulin segment, says there is a need for clarity in the policy framework as the pharmaceutical business is risky and requires huge investments. This comes against the backdrop of new price caps imposed on several ...
 Business Standard4 days ago
Bioresearch Online

Eli Lilly announces encouraging results from Alzheimer's disease analyses

Eli Lilly and Company has announced results from analyses of five datasets evaluating the relationship between cognitive and functional impairment in patients with mild Alzheimer's disease in the natural course of the disease. Analysis findings ...
 Individual.com5 days ago Lilly Study Suggests Cognitive-Function Impairment Link In AD  Bioresearch Online6 days ago Eli Lilly and Company Release: New Study Shows Beta-Amyloid Imaging Is Associated With Altered Diagnosis And Management Of Alzheimer's Disease  BioSpace1 week ago Eli Lilly : New Study Shows Beta-Amyloid Imaging is Associated with Altered Diagnosis and Management of Alzheimer's Disease  4 Traders1 week ago

Anthera Pharmaceuticals Buys Sollpura (liprotamase) for Exocrine Pancreatic Insufficiency from Eli Lilly and Company

Anthera Pharmaceuticals has acquired Sollpura (liprotamase), a novel investigational Pancreatic Enzyme Replacement Therapy ("PERT") from Eli Lilly and Company. According to a release from the Company, Sollpura is a soluble, stable and non-porcine ...
 Individual.com5 days ago Anthera Pharmaceuticals Inc. (NASDAQ:ANTH): Acquires Sollpura┬« From Eli Lilly and Company  Live Trading News6 days ago Acquisition of Sollpura from Eli Lilly and Company by Anthera Pharmaceuticals, Inc Call - Anthera Pharmaceuticals, Inc., - Earnings Transcript  Research and Markets1 week ago Anthera Acquires Sollpura from Eli Lilly  Yahoo! Finance5 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - eli lilly
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less